InnovAge: Operational Momentum Is Winning Out Over The Risks

Impact · against what's priced in

InnovAge demonstrates significant operational momentum with concrete EBITDA guidance of $105–$115M for fiscal 2027. The shift toward capacity utilization over capital-intensive expansion improves the cash flow profile.

INNV+0.70

No priced-in read yet

In context

The company is providing concrete profitability targets for fiscal 2027, forecasting adjusted EBITDA of $105–$115M and revenue growth up to $1.085B.

Read from the article alone

• cash flow▲29%
• guidance▲12%
• revenue growth▲3%
• healthcare
• INNV
• capacity utilization
• ebitda